AS Grindeks Company Review & Valuation GRD1R

About AS Grindeks

AS Grindeks, a pharmaceutical company, engages in the research, development, manufacture, and sale of generics and active pharmaceutical ingredients primarily in Latvia. It operates through Final Dosage Forms and Active Pharmaceutical Ingredients segments. The company offers heart and cardiovascular drugs, CNS drugs, and anti-cancer medication therapeutic groups under the Mildronate and Ftorafur brands; and Oxytocin, a hormone that is used as a medication to facilitate childbirth. Its final dosage forms portfolio includes solid form products, as well as injections, ointments, and syrups. The company also offers research and development, registration, contract manufacturing, and analytical services. It also exports its products to 77 countries. AS Grindeks was incorporated in 1991 and is headquartered in Riga, Latvia.

Primary Stock Exchange Listings

Ticker Symbol:

GRD1R

XTAL

Stock Price

Performance

Registration required

Please login or create a free account to view all available contents of this section.

Create Account

Health Check

Registration required

Please login or create a free account to view all available contents of this section.

Create Account

Financial Reports

Registration required

Please login or create a free account to view all available contents of this section.

Create Account

Similar Companies

↑ back to top